George Lasezkay
Chief Executive Officer at CLEARSIDE BIOMEDICAL, INC.
Net worth: 535 870 $ as of 2024-05-30
Profile
George M.
Lasezkay's current job(s) include being the President, Chief Executive Officer & Director at Clearside Biomedical, Inc. since 2020, Director at Amakem NV since 2014, and Director at TheraVida, Inc. since 2014.
Formerly, Dr. Lasezkay held positions such as Director at CollaGenex Pharmaceuticals, Inc. from 2005 to 2008, Director at Acuity Pharmaceuticals, Inc., Director at Sucampo Pharmaceuticals LLC, Director at Vaneltix Pharma, Inc. from 2004 to 2009, Vice President-Development at Allergan, Inc. from 1989 to 2002, Member-Supervisory Board at Novagali Pharma SA, EVP-Legal Affairs & General Counsel at Acucela, Inc. from 2015 to 2016, and President at Horizon Pharma Group from 2005 to 2015.
He also served as Executive Vice President & General Counsel at Kubota Pharmaceutical Holdings Co. Ltd.Dr. Lasezkay obtained his undergraduate and doctorate degrees from the State University of New York at Buffalo and his graduate degree from the University of Southern California Gould School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-14 | 382,764 ( 0.51% ) | 535 870 $ | 2024-05-30 |
George Lasezkay active positions
| Companies | Position | Start |
|---|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Chief Executive Officer | 2019-04-07 |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Director/Board Member | 2012-05-06 |
TheraVida, Inc.
 TheraVida, Inc. Pharmaceuticals: MajorHealth Technology TheraVida, Inc. develops and commercializes therapeutic products that improve the lives of patients. The firm's products help to treatment of overactive bladder and urge urinary incontinence. It develops a portfolio of combination pharmaceutical products in the fields of urology and central nervous system disorders. The company was founded by Mehdi Paborji in 2005 and is headquartered in Chapel Hill, NC. | Director/Board Member | 2014-11-30 |
Former positions of George Lasezkay
| Companies | Position | End |
|---|---|---|
| ACUCELA INC | General Counsel | 2016-06-30 |
Horizon Pharma Group
 Horizon Pharma Group Miscellaneous Commercial ServicesCommercial Services Horizon Pharma Group provides life sciences consultancy services. | President | 2015-11-30 |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Director/Board Member | 2009-11-30 |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Director/Board Member | 2008-04-10 |
Acuity Pharmaceuticals, Inc.
 Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA. | Director/Board Member | 2007-05-16 |
Training of George Lasezkay
| State University of New York at Buffalo | Doctorate Degree |
| University of Southern California Gould School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| CLEARSIDE BIOMEDICAL, INC. | Health Technology |
| Private companies | 10 |
|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Health Technology |
Acuity Pharmaceuticals, Inc.
Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA. | Commercial Services |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Health Technology |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Health Technology |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Health Services |
Horizon Pharma Group
Horizon Pharma Group Miscellaneous Commercial ServicesCommercial Services Horizon Pharma Group provides life sciences consultancy services. | Commercial Services |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
TheraVida, Inc.
TheraVida, Inc. Pharmaceuticals: MajorHealth Technology TheraVida, Inc. develops and commercializes therapeutic products that improve the lives of patients. The firm's products help to treatment of overactive bladder and urge urinary incontinence. It develops a portfolio of combination pharmaceutical products in the fields of urology and central nervous system disorders. The company was founded by Mehdi Paborji in 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
- Stock Market
- Insiders
- George Lasezkay
